✦ LIBER ✦

Hepatocellular carcinoma and non-alcoholic fatty liver disease: Major liver diseases emerging from the Asia-Pacific Region

✍ Scribed by HIROMASA ISHII

Book ID: 108950601
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 33 KB
Volume: 21
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2005.04238.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-alcoholic fatty liver disease in the

Non-alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines

✍ Shivakumar Chitturi; Geoffrey C Farrell; Etsuko Hashimoto; Toshiji Saibara; Geor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

How common is non-alcoholic fatty liver

How common is non-alcoholic fatty liver disease in the Asia–Pacific region and are there local differences?

✍ Deepak N Amarapurkar; Estsuko Hashimoto; Laurentius A Lesmana; José D Sollano; P 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Guidelines for the assessment and manage

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia–Pacific region: Executive summary

✍ Geoffrey C Farrell; Shivakumar Chitturi; George KK Lau; José D Sollano; for the 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

What are the risk factors and settings f

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia–Pacific?

✍ Jian-Gao Fan; Toshiji Saibara; Shivakumar Chitturi; Byong Ik Kim; Joseph J Y Sun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Non-alcoholic fatty liver disease progre

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis

✍ Judith Ertle; Alexander Dechêne; Jan-Peter Sowa; Volker Penndorf; Kerstin Herzer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 402 KB

## Abstract Non‐alcoholic fatty liver disease (NAFLD) is the most common liver disease in developed countries, and accumulating evidence suggests it as the hepatic manifestation of the metabolic syndrome (MS). Although the published prevalence of hepatocellular carcinoma (HCC) is low in NAFLD/NASH

How should we manage patients with non-a

How should we manage patients with non-alcoholic fatty liver disease in 2007?

✍ Henry L-Y Chan; H Janaka De Silva; Nancy W-Y Leung; Seng-Gee Lim; Geoffrey C Far 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB